- Investigation of Serum Angiotensin II Type 1 Receptor Antibodies at the Time of Renal Allograft Rejection
-
Lee H, Kim JI, Moon IS, Chung BH, Yang CW, Kim Y, Han K, Oh EJ
- KMID: 2363203
- Ann Lab Med.
- 2015 May;35(3):314-320.
- doi: 10.3343/alm.2015.35.3.214
BACKGROUND: Angiotensin II type 1 receptor (AT1R) is responsible for cardiovascular effects mediated by angiotensin II. This study aimed to investigate the impact of antibodies directed against AT1R (anti-AT1R) in... -
- CITED
-
- Close
- SHARE
-
- Close
- Higher infiltration by Th17 cells compared with regulatory T cells is associated with severe acute T-cell-mediated graft rejection
-
Chung BH, Oh HJ, Piao SG, Sun IO, Kang SH, Choi SR, Park HS, Choi BS, Choi YJ, Park CW, Kim YS, Cho ML, Yang CW
- KMID: 1025166
- Exp Mol Med.
- 2011 Nov;43(11):630-637.
- doi: 10.3858/emm.2011.43.11.071
The aim of this study was to evaluate whether the Th17 and Treg cell infiltration into allograft tissue is associated with the severity of allograft dysfunction and tissue injury in... -
- CITED
-
- Close
- SHARE
-
- Close
- Sirolimus Conversion Efficacy for Graft Function Improvement and Histopathology in Renal Recipients with Mild to Moderate Renal Insufficiency
-
Joo DJ, Yang CW, Jeong HJ, Lim BJ, Huh KH, Chung BH, Choi YJ, Kang SW, Kim YS
- KMID: 2129600
- J Korean Med Sci.
- 2014 Aug;29(8):1069-1076.
- doi: 10.3346/jkms.2014.29.8.1069
This study was designed to evaluate whether sirolimus (SRL) conversion effectively improves renal function and histopathology in calcineurin inhibitor (CNI)-treated renal recipients with mild to moderate renal insufficiency. SRL conversion... -
- CITED
-
- Close
- SHARE
-
- Close
